City Research Online

Enoch, J., Matthews, D., Ghulakhszian, A. , Sekhon, M., Callaghan, T., Crabb, D. P. ORCID: 0000-0001-8611-1155, Dinah, C. & Taylor, D. ORCID: 0000-0001-8261-5225view all authors (2025). Implementing patient and public involvement (PPI) in eye research: reflections from developing a research study on Geographic Atrophy treatment acceptability. Research Involvement and Engagement, 11, article number 90. doi: 10.1186/s40900-025-00747-7

Dinah, C. ORCID: 0000-0002-0815-4771, Enoch, J. ORCID: 0000-0002-4614-6676, Ghulakhszian, A. , Sekhon, M., Crabb, D. P. ORCID: 0000-0001-8611-1155 & Taylor, D. J. ORCID: 0000-0001-8261-5225view all authors (2024). Patient acceptability of intravitreal complement inhibitors in geographic atrophy (GA): protocol for a UK-based cross-sectional study. BMJ Open, 14(1), article number e075713. doi: 10.1136/bmjopen-2023-075713

Enoch, J. ORCID: 0000-0002-4614-6676, Ghulakhszian, A., Sekhon, M. , Crabb, D. P. ORCID: 0000-0001-8611-1155, Taylor, D. J. ORCID: 0000-0001-8261-5225 & Dinah, C.view all authors (2023). Exploring patient acceptability of emerging intravitreal therapies for geographic atrophy: A mixed-methods study. Eye, 37(17), pp. 3634-3642. doi: 10.1038/s41433-023-02571-3

Enoch, J. ORCID: 0000-0002-4614-6676, Ghulakhszian, A., Sekhon, M. , Crabb, D. P. ORCID: 0000-0001-8611-1155, Taylor, D. J. ORCID: 0000-0001-8261-5225 & Dinah, C.view all authors (2023). Piloting a forced-choice task to elicit treatment preferences in geographic atrophy. BMC Research Notes, 16(1), article number 244. doi: 10.1186/s13104-023-06531-8

Enoch, J. ORCID: 0000-0002-4614-6676, Ghulakhszian, A., Sekhon, M. , Crabb, D. P. ORCID: 0000-0001-8611-1155, Taylor, D. J. ORCID: 0000-0001-8261-5225 & Dinah, C.view all authors (2023). Towards a Therapy for Geographic Atrophy: A Patient's Experience. Patient Prefer Adherence, 17, pp. 299-310. doi: 10.2147/ppa.s386662

Dinah, C., Enoch, J. ORCID: 0000-0002-4614-6676, Ghulakhszian, A. , Taylor, D. J. ORCID: 0000-0001-8261-5225 & Crabb, D. P. ORCID: 0000-0001-8754-3902view all authors (2022). Intravitreal treatment for geographic atrophy: coming soon to a patient near you?. Eye, 36(5), pp. 1121-1123. doi: 10.1038/s41433-021-01591-1

Enoch, J. ORCID: 0000-0002-4614-6676, Ghulakhszian, A., Crabb, D. P. ORCID: 0000-0001-8754-3902 , Dinah, C. & Taylor, D. J. ORCID: 0000-0001-8261-5225view all authors (2021). Acceptability of intravitreal injections in geographic atrophy: protocol for a mixed-methods pilot study. BMJ Open, 11(4), article number e049495. doi: 10.1136/bmjopen-2021-049495

Sivaprasad, S., Vasconcelos, J. C., Prevost, A. T. , Holmes, H., Hykin, P., George, S., Murphy, C., Kelly, J., Arden, G. B., Ahfat, F., Bhatnagar, A., Narendran, N., Chavan, R., Cole, A., Crosby-Nwaobi, R., Patrao, N., Menon, D., Hogg, C., Rubin, G., Leitch-Devlin, L., Egan, C., Shah, N., Mansour, T., Peto, T., Eleftheriadis, H., Gibson, J., Ghulakhszian, A., Vafidis, G., Hughes, E., Jafree, A., Menon, G., Prakash, P., Sandinha, M., Smith, R., Scanlon, P., Chave, S., Aldington, S., Dale, A., Hood, G., Hitman, G. A., Crabb, D. P. ORCID: 0000-0001-8754-3902, Denniston, A., Lewin, D., Grierson, I., Walker, S., Sturt, J. & Sahu, D.view all authors (2018). Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial. The Lancet Diabetes and Endocrinology, 6(5), pp. 382-391. doi: 10.1016/s2213-8587(18)30036-6